Cue Biopharma, Inc. - CUE
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | SVP, GENERAL COUNSEL | A | A | 200,000.0 | 0.0 | 0.0 | 200,000.0 | View | |
| Apr 10, 2026 | CHIEF BUSINESS OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Apr 10, 2026 | CHIEF DEVELOPMENT OFFICER | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 06, 2026 | — | A | A | 24,400.0 | 0.0 | 0.0 | 24,400.0 | View | |
| Jan 02, 2026 | — | P | A | 77,417.0 | 0.3016 | 23,348.97 | 323,857.0 | View | |
| Jan 02, 2026 | — | P | A | 78,116.0 | 0.3114 | 24,325.32 | 246,440.0 | View | |
| Jan 02, 2026 | — | P | A | 86,947.0 | 0.3174 | 27,596.98 | 168,324.0 | View | |
| Jan 02, 2026 | — | P | A | 77,148.0 | 0.3003 | 23,167.54 | 81,377.0 | View | |
| Jan 02, 2026 | — | P | A | 4,229.0 | 0.3094 | 1,308.45 | 4,229.0 | View | |
| Dec 05, 2025 | SVP, GENERAL COUNSEL | A | A | 70,000.0 | 0.0 | 0.0 | 70,000.0 | View | |
| Dec 05, 2025 | SVP, GENERAL COUNSEL | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Nov 25, 2025 | CHIEF BUSINESS OFFICER | A | A | 125,000.0 | 0.0 | 0.0 | 125,000.0 | View | |
| Nov 25, 2025 | CHIEF DEVELOPMENT OFFICER | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View |